HCV Patient Care for the Non-Hepatologist: Management of Chronic HCV in the Era of Protease Inhibitors
With an increasing demand for HCV care in the U.S.and not enough hepatologists to meet this demand — especially outside of larger metropolitan areas — general practce gastroenterologists are needed to help fill the gap. This webinar is intended to help enhance their ability to effectively and efficiently treat most HCV-positive patients.
It will also be valuable to all clinicians since it addresses the changes in treatment and expected outcomes of the direct-acting drugs telapravir and boceprevir. Additional topics to be covered, but not limited to, will include:
- Epidemiology and natural history of HCV infection.
- Screening and diagnosis of HCV, including genotypes and implications for treatment.
- Selecting and dosing treatment options.
- Identifying and managing treatment side effects and assessing treatment success.
- Treatment failures.
- Cost-efficient patient management.
This webinar is part two of a two-part series. Click here to view the first webinar.
Gastroenterologists, physician assistants, nurse practitioners, trainees
Course Director and Faculty
Vinod K. Rustgi, MD
Medical Director, Liver Transplantation
Metropolitan Liver Diseases/Gastroenterology Center
Stuart C. Gordon, MD
K. Rajender Reddy, MD
Stuart C. Gordon - Advisory Committees or Review Panels: Merck & Co, Gilead Sciences Inc; Consulting: Achillion Pharmaceutical, CVS-Caremark; Speaking and Teaching: Merck & Co, Gilead Sciences Inc, Vertex Pharmaceuticals
For for questions related to the webinar, contact Sandra Megally at firstname.lastname@example.org.